NO20003960D0 - Salter av paroksetin - Google Patents
Salter av paroksetinInfo
- Publication number
- NO20003960D0 NO20003960D0 NO20003960A NO20003960A NO20003960D0 NO 20003960 D0 NO20003960 D0 NO 20003960D0 NO 20003960 A NO20003960 A NO 20003960A NO 20003960 A NO20003960 A NO 20003960A NO 20003960 D0 NO20003960 D0 NO 20003960D0
- Authority
- NO
- Norway
- Prior art keywords
- paroxetine
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802664.4A GB9802664D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802655.2A GB9802655D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802654.5A GB9802654D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802656.0A GB9802656D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802646.1A GB9802646D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802659.4A GB9802659D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802665.1A GB9802665D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802645.3A GB9802645D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802640.4A GB9802640D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802638.8A GB9802638D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802657.8A GB9802657D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802658.6A GB9802658D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802639.6A GB9802639D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802661.0A GB9802661D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802644.6A GB9802644D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802698.2A GB9802698D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802653.7A GB9802653D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9817360.2A GB9817360D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817364.4A GB9817364D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817359.4A GB9817359D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817340.4A GB9817340D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817317.2A GB9817317D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817321.4A GB9817321D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817344.6A GB9817344D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817309.9A GB9817309D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817307.3A GB9817307D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817322.2A GB9817322D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9817320.6A GB9817320D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9826172.0A GB9826172D0 (en) | 1998-11-30 | 1998-11-30 | Novel compound |
GBGB9826173.8A GB9826173D0 (en) | 1998-11-30 | 1998-11-30 | Novel compounds |
GBGB9827277.6A GB9827277D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
GBGB9827341.0A GB9827341D0 (en) | 1998-12-11 | 1998-12-11 | Novel compounds |
GBGB9828775.8A GB9828775D0 (en) | 1998-12-29 | 1998-12-29 | Novel compounds |
PCT/GB1999/000380 WO1999040084A1 (en) | 1998-02-06 | 1999-02-05 | Salts of paroxetine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003960D0 true NO20003960D0 (no) | 2000-08-04 |
NO20003960L NO20003960L (no) | 2000-09-25 |
Family
ID=27586915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003960A NO20003960L (no) | 1998-02-06 | 2000-08-04 | Salter av paroxsetine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1053234A1 (no) |
JP (1) | JP2002505254A (no) |
KR (1) | KR20010040711A (no) |
BG (1) | BG104737A (no) |
CA (1) | CA2319652A1 (no) |
EA (1) | EA200000815A1 (no) |
IL (1) | IL137684A0 (no) |
NO (1) | NO20003960L (no) |
PL (1) | PL342295A1 (no) |
SK (1) | SK11812000A3 (no) |
WO (1) | WO1999040084A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9814316D0 (en) * | 1998-07-02 | 1998-09-02 | Smithkline Beecham Plc | Novel compounds |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
EP1102764A1 (en) * | 1998-08-08 | 2001-05-30 | Smithkline Beecham Plc | Paroxetine salts |
GB9827431D0 (en) * | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
WO2000078290A2 (en) * | 1999-06-22 | 2000-12-28 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a salt of paroxetine |
HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
CA2431545A1 (en) * | 2001-01-05 | 2002-07-11 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
CA2456233A1 (en) * | 2001-08-02 | 2003-03-13 | Spurcourt Limited | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
CN108218844B (zh) * | 2018-03-08 | 2021-01-19 | 合肥科大生物技术有限公司 | 一种美金刚帕罗西汀共晶盐及其制备方法、药物组合物、应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
-
1999
- 1999-02-05 IL IL13768499A patent/IL137684A0/xx unknown
- 1999-02-05 EP EP99904971A patent/EP1053234A1/en not_active Withdrawn
- 1999-02-05 PL PL99342295A patent/PL342295A1/xx not_active Application Discontinuation
- 1999-02-05 KR KR1020007008591A patent/KR20010040711A/ko not_active Application Discontinuation
- 1999-02-05 CA CA002319652A patent/CA2319652A1/en not_active Abandoned
- 1999-02-05 SK SK1181-2000A patent/SK11812000A3/sk unknown
- 1999-02-05 EA EA200000815A patent/EA200000815A1/ru unknown
- 1999-02-05 WO PCT/GB1999/000380 patent/WO1999040084A1/en not_active Application Discontinuation
- 1999-02-05 JP JP2000530513A patent/JP2002505254A/ja active Pending
-
2000
- 2000-08-04 NO NO20003960A patent/NO20003960L/no not_active Application Discontinuation
- 2000-08-30 BG BG104737A patent/BG104737A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EA200000815A1 (ru) | 2001-02-26 |
EP1053234A1 (en) | 2000-11-22 |
CA2319652A1 (en) | 1999-08-12 |
BG104737A (en) | 2001-07-31 |
SK11812000A3 (sk) | 2001-08-06 |
IL137684A0 (en) | 2001-10-31 |
NO20003960L (no) | 2000-09-25 |
KR20010040711A (ko) | 2001-05-15 |
WO1999040084A1 (en) | 1999-08-12 |
PL342295A1 (en) | 2001-06-04 |
JP2002505254A (ja) | 2002-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60000003T2 (de) | Paroxetinmethansulfonat | |
CY2014027I2 (el) | Xρηση διαλκυλο φουμαρικων εστερων | |
ID27092A (id) | Pembuatan ftalat anhidrida | |
IS2277B (is) | Meðferðarlegar bíarýl afleiður | |
EE200300007A (et) | Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid | |
NO20011083L (no) | Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH | |
NO20003960D0 (no) | Salter av paroksetin | |
PT1246817E (pt) | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo | |
NO20006547D0 (no) | Salter av paroxetine | |
NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
DE29822563U1 (de) | Implantat | |
NO20010553L (no) | Krystallinske former av osanetant | |
DE50009938D1 (de) | Verwendung von nanoskaligen wachsen | |
EE200100381A (et) | Morfolinobensamiidi uued soolad | |
EE200100017A (et) | N-tert-butüülhüdroksüülamiini uued soolad | |
FR2802852B3 (fr) | Production d'elements figures | |
PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
PT1175417E (pt) | Compostos substituidos de benzolactamas | |
NO20004583D0 (no) | Krystallinsk form av paroxetine | |
FI981803A0 (fi) | Menetelmä saostumien muodostumisen estämiseksi | |
NO20016030D0 (no) | Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin | |
PT1232141E (pt) | Eteres de o-desmetil-venlafaxina | |
NO20005683D0 (no) | Ny formulering inneholdende paroxetin | |
NO20013453D0 (no) | Fremgangsmåte for fremstilling av salter av cyanobenzylaminer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |